Anti-inflammatory, Analgesic and Ulcerogenic Properties of S-(+)-Ibuproxam, Racemic Ibuproxam-β-cyclodextrin and S-(+)-Ibuproxam-β-cyclodextrin

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 11, 1996, Pages 1153-1157

  Bole Vunduk, Breda ^a   Verhnjak, Katarina ^b   Zmitek, J ^a  

^a LEK Pharmaceut/Chem Company DD   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENEACETAMIDE DERIVATIVE; BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; CYCLODEXTRIN; HYDROXAMIC ACID; IBUPROFEN; IBUPROXAM; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ARTICLE; CHEMISTRY; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECT; FEMALE; INFLAMMATION; MALE; MOUSE; MUSCLE CONTRACTION; PAIN ASSESSMENT; RAT; STEREOISOMERISM; STOMACH MUCOSA; SYNTHESIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZENEACETAMIDES; BETA-CYCLODEXTRINS; CYCLODEXTRINS; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; FEMALE; GASTRIC MUCOSA; HYDROXAMIC ACIDS; IBUPROFEN; INFLAMMATION; MALE; MICE; MUSCLE CONTRACTION; PAIN MEASUREMENT; RATS; STEREOISOMERISM;

EID: 0030278773     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb03912.x     Document Type: Article

References (22)

1. Adams, S. S., Bresloff, P., Mason C. G. (1976) Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (-)-isomer. J. Pharm. Pharmacol. 28: 256-257
2. Cashin, C. H., Dawson, W., Kitchen E. A. (1977) The pharmacology of benoxaprofen (2-(4-chlorophenyl)-α-methyl)-5-benzoxazole acetic acid), LRCL 3794, a new compound with anti-inflammatory activity apparently unrelated to inhibition of prostaglandin synthesis. J. Pharm. Pharmacol. 29: 330-336
3. De Camp, W. H. (1989) The PDA perspective on the development of stereoisomers. Chirality 1: 15-19
4. Geisslinger, G., Stock, K. P., Bach, G. L., Loew, D., Brune, K. (1989) Pharmacological differences between R(-)- and S(+)-ibuprofen. Agents Actions 2: 455-457
5. Heydorn, W. E. (1995) Developing racemic mixtures vs. single isomers in the U.S. Pharmaceutical News 2: 19-21
6. Kaiser, D. G., VanGiessen, G. J., Reischer, R. J., Wechter, W. J. (1976) Isomeric inversion of ibuprofen (R)-enantiomer in humans. J. Pharm. Sci. 65: 269-273
7. Krisch, I., Bole-Vunduk, B., Pepelnak, M., Lavric, B., Ocvirk, A., Budihna, M. V., Sket, D. (1994) Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841. J. Pharmacol. Exp. Ther. 271: 343-352
8. Lee, C. R., Balfour, J. A. (1994) Piroxicam-β-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states. Drugs 48: 907-929
9. Levi, S., Shaw-Smith, C. (1994) Non-steroidal anti-inflammatory drugs: how do they damage the gut? Br. J. Rheumatol. 33: 605-612
10. Loew, D., Schuster, O. (1989) Why ibuprofen racemate if S(+)-ibuprofen is effective? (Warum Ibuprofen-Racemat, wenn S(+)-Ibuprofen wirt? Dtsch. Apoth. Ztg. 129: 669-671
11. Nakamura, Y., Yamaguchi, T., Takahashi, S., Hashimoto, S., Iwatani, K., Nagagawa, Y. (1981) Optical isomerization mechanism of R(-)-hydratropic acid derivatives. J. Pharmacobiodyn. 4: s-1
12. Nuutinen, L. S., Laitinen, J. O., Salomiäki, T. E. (1993) A risk-benefit appraisal of injectable NSAIDs in the management of postoperative pain. Drug Safety 9: 380-393
13. Orzalesi, G., Selleri, R., Caldini, O., Volpato, I., Innocenti, F., Colome, J., Sacristan, A., Varez, G. (1977) Ibuproxam and ibuprofen. Arzneim. Forsch. 27: 1006-1012
14. Orzalesi, G., Mari, F., Bertol, E., Selleri, R., Pisaturo, G. (1980) Anti-inflammatory agents: determination of ibuproxam and its metabolite in humans. Arzneim. Forsch. 30: 1607-1609
15. Rainsford, K. D. (1989) Mechanism of gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. Scand. J. Gastroenterol. (Suppl. 24) 163: 9-16
16. Rainsford, K. D. (1990) NSAID gastropathy: novel physiochemical approaches for reducing gastric mucosal injury by drug complexation with cyclodextrins. Drug Invest. (Suppl. 2). 4: 3-10
17. Szejtli, J. (1994) Medicinal applications of cyclodextrins. Med. Res. Rev. 14: 353-386
18. Tallarida, R. J., Murray, R. B. (1987) Manual of Pharmacologic Calculations with Computer Programs. 2nd ed. Springer-Verlag, New York, pp 153-159
19. Wallace, J. L., Cirino, G. (1994) The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs. Trends Pharmacol. Sci. 15: 405-406
20. Winter, C. A., Risley, E. A., Nuss, G. W. (1962) Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exptl Biol. Med. 111: 544-547
21. Zmitek, J., Kocjan, D., Rusjakovski, B., Bukovec, N., Bukovec, P. (1992) Inclusion complex of ibuproxam, 2-(4-isobutylphenyl)-propiohydroxamic acid, with β-cyclodextrin. Acta Pharm. 42: 85-90
22. Zmitek, J., Verhnjak, K., Urleb, U., Kotnik S. (1995). Synthesis of (+)-(S)-ibuproxam and preparation of some new complexes of racemic and (+)-(S)-ibuproxam with β-cyclodextrin and its derivatives. Chirality 7: 206-210